assoc. prof. altman | molecular response to gilteritinib, a flt3i, in r/r aml, flt3
Published 7 years ago • 102 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
3:01
assoc. prof. perl | phase iii study of gilteritinib vs salvage ctx in r/r flt3 mutation aml
-
1:09
dr. altman on gilteritinib in patients with relapsed/refractory aml
-
2:43
what is flt3-positive aml? what is gilteritinib? #aml
-
5:32
gilteritinib in flt3 aml
-
10:54
gilteritinib for flt3-mutant aml
-
4:01
deep molecular response to gilteritinib in chrysalis trial
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
2:27
gilteritinib maintenance after allogeneic transplantation in flt3-mutated aml
-
4:10
leah arora - acute myeloid lukaemia (aml) - spot leukaemia
-
1:24
mark levis, md, phd, discusses what we've learned about gilteritinib in flt3 mutated aml patients
-
3:21
admiral analysis: survival by mutation status in gilteritinib-treated flt3 r/r aml
-
2:15
real-world analysis of gilteritinib for r/r flt3-mutated aml
-
2:35
gilteritinib, venetoclax, low-dose cytarabine, and actinomycin d in flt3-mutated aml
-
1:33
is gilteritinib the new breakthrough in the treatment of flt3-mutated aml?
-
20:29
role of flt3 inhibitors and other novel agents in aml
-
1:15
dr. patel on the role of gilteritinib in flt3 aml
-
1:37
emerging mutations at relapse in flt3-mutated r/r aml on gilteritinib
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
6:35
costem aml highlights: sct & mrd status, sorafenib maintenance & gilteritinib in flt3 aml
-
3:17
prof. neil shah | ash 2017 | gilteritinib resistance in r/r flt3-mutated aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
1:49
altman: gilteritinib for acute myeloid leukemia